Finance

Lists
XBIT:NASDAQ
XBiotech Inc
$1.96
0.00%
(0.00) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XBIT...
Open
$1.95
High
$1.99
Low
$1.95
Mkt. cap
59.76M
Avg. vol.
77.24K
Volume
105.42K
52-wk high
$2.73
52-wk low
$1.80
EPS
-$1.48
Beta
0.76
Shares outstanding
30.49M
No. of employees
87
Open
$1.95
High
$1.99
Low
$1.95
Mkt. cap
59.76M
Avg. vol.
77.24K
Volume
105.42K
52-wk high
$2.73
52-wk low
$1.80
EPS
-$1.48
Beta
0.76
Shares outstanding
30.49M
No. of employees
87
News stories
From web sources and news partners
Profile
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
About XBiotech Inc
CEO-
Employees87
Founded2005
HeadquartersAustin, Texas, United States
SectorHealth Care
IndustryBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
25.36M
5.21M
5.30M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.40M
1.07M
850.00K
-
Operating expense
29.76M
6.27M
6.15M
-
Total operating expenses
29.76M
6.27M
6.15M
-
Operating income
-29.76M
-6.27M
-6.15M
-
Other non operating income
-8.00K
1.04M
-9.00K
-
EBT including unusual items
-26.82M
-5.46M
-6.68M
-
EBT excluding unusual items
-27.37M
-5.46M
-6.68M
-
Income tax expense
76.00K
49.00K
46.00K
-
Effective tax rate
-0.28%
-0.90%
-0.69%
-
Other operating expenses
-
-
-
-
Net income
-26.89M
-5.50M
-6.73M
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.22M
914.00K
885.00K
-
Interest expense
-
-
-
-
Net interest expenses
1.22M
914.00K
885.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-29.38M
-5.94M
-5.84M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps